Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis
{{output}}
The introduction of immunosuppressive therapy for ANCA-associated vasculitis (AAV) has greatly improved outcomes, though patients now accumulate damage from vasculitis activity and adverse effects of treatment. Prediction of treatment outcomes using gene varia... ...
